Vertebral Fracture Risk After Once-Weekly Teriparatide Injections: Follow-Up Study of Teriparatide Once-Weekly Efficacy Research (TOWER) Trial

Current Medical Research and Opinion- United Kingdom

doi 10.1185/03007995.2012.761956

Full Text

Abstract

Available in

Categories

Date

January 17, 2013

Authors

Toshitsugu Sugimoto

Masataka Shiraki

Hideaki Kishimoto

Tatsuhiko Kuroda

Toshitaka Nakamura

Publisher

Informa Healthcare

Related search

Nonsurgical Corrective Union of Osteoporotic Vertebral Fracture With Once-Weekly Teriparatide

Case Reports in Orthopedics

English

Study of Twice-Weekly Injections of Teriparatide by Comparing Efficacy With Once-Weekly Injections in Osteoporosis Patients: The TWICE Study

Osteoporosis International

English

Treatment Responses With Once-Weekly Teriparatide Therapy for Osteoporosis

Osteoporosis International

English

New Simulation Model for Bone Formation Markers in Osteoporosis Patients Treated With Once-Weekly Teriparatide

English

Comparison of the Effects of Once-Weekly and Once-Daily rhPTH (1-34) Injections on Promoting Fracture Healing in Rodents

Journal of Orthopaedic Research

Sports Medicine

English

Profile of Changes in Bone Turnover Markers During Once-Weekly Teriparatide Administration for 24 Weeks in Postmenopausal Women With Osteoporosis

Osteoporosis International

English

Once-Weekly Teriparatide Increases Bone Mineral Density in the Distal 1/10 Radius, but Not in the Distal 1/3 Radius

Multidisciplinary

English

FRAX and the Effect of Teriparatide on Vertebral and Non-Vertebral Fracture

Osteoporosis International

English

Dulaglutide: Third Once-Weekly GLP-1 Agonist for Type 2 Diabetes

English